Back

Efficacy of digitoxin over time in patients with HFrEF: further analysis of DIGIT-HF

29 August 2026 (17:45 - 18:00)
Organised by: Logo
Congress Presentation Part of: Digitalis glycosides in heart failure: back to the future! Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Udo Bavendiek

Hannover Medical School, Hannover (Germany)

3 More presentations in this session

Presentation thumbnail
Early or late, benefits of digoxin reconsidered in HFrEF: Insights from the Digitalis Investigation Group Trial (DIG)
Doctor M. Chimura (Glasgow, GB)
Presentation thumbnail
Low-dose Digoxin in Women and Men with Heart Failure: Data from DECISION
Professor D. van Veldhuisen (Groningen, NL)
Presentation thumbnail
Long-term cost-effectiveness of digitoxin in heart failure with reduced ejection fraction analyzed in DIGIT-HF
Doctor P. Boettger (Giessen, DE)

Access the full session

Session thumbnail
Digitalis glycosides in heart failure: back to the future!

The Event

Event poster

ESC Congress 2026

29 August 2026 17:45 CET
You may be interested in
thumbnail
Congress Presentation
Back to the future - digitalis therapy reloaded? The suitability for digitoxin treatment in a real-world, outpatient heart failure patient cohort
9 May 2026
thumbnail
Congress Presentation
Late improvement of left ventricular ejection fraction in patients with persistent severe systolic dysfunction under guideline-directed medical therapy
11 December 2020
thumbnail
Congress Presentation
A day in the life of digoxin
21 May 2023
thumbnail
Congress Session
Hottest trials and trial updates (2)
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources